Cellular cardiomyoplasty: Its past, present, and future

Methods in Molecular Biology

Volumn 1036, Issue , 2013, Pages 1-17

  Lamb, Elizabeth K ^a   Kao, Grace W ^a   Kao, Race L ^a  

^a East Tennessee State University   (United States)

Author keywords

Adipose tissue stem cells; Bone marrow stem cells; Cardiac stem cells; Cellular cardiomyoplasty; Clinical trials; Induced pluripotent stem cells; Skeletal muscle stem cell

Indexed keywords

ADIPOSE TISSUE; ARTICLE; CARDIOMYOPLASTY; CELL THERAPY; CELLULAR CARDIOMYOPLASTY; HEART FAILURE; HEART FUNCTION; HEART MUSCLE; HEART MUSCLE METABOLISM; HEART PERFUSION; HEART TRANSPLANTATION; HEMATOPOIETIC STEM CELL; HUMAN; MESENCHYMAL STEM CELL; MYOBLAST; NONHUMAN; OUTCOME ASSESSMENT; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SATELLITE CELL; SKELETAL MUSCLE; STEM CELL;

CARDIOMYOPLASTY; HEART DISEASES; HUMANS; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84880107627     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-511-8_1     Document Type: Article

References (98)

1. Roger VL, Go AS, Lloyd-Jones DM et al (2011) Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 123:e18-e209
2. Ang KL, Shenje LT, Reuter S et al (2010) Limitations of conventional approaches to identify myocyte nuclei in histologic sections of the heart. Am J Physiol Cell Physiol 298:C1603-C1609
3. Soonpaa MH, Field LJ (1997) Assessment of cardiomyocyte DNA synthesis in normal and injured adult mouse hearts. Am J Physiol 272:H220-H226
4. Bergmann O, Bhardwaj RD, Bernard S et al (2009) Evidence for cardiomyocyte renewal in humans. Science 324:98-102
5. Kao RL, Browder W, Li C (2009) Cellular cardiomyoplasty: what have we learned? Asian Cardiovasc Thorac Ann 17:89-101
6. Steinhauser ML, Lee RT (2011) Regeneration of the heart. EMBO Mol Med 3:701-712
7. Lafl amme MA, Murry CE (2011) Heart regeneration. Nature 473:326-335
8. Lafl amme MA, Myerson D, Saffi tz JE, Murry CE (2002) Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts. Circ Res 90:634-640
9. Müller P, Pfeiffer P, Koglin J et al (2002) Cardiomyocytes of noncardiac origin in myocardial biopsies of human transplanted hearts. Circulation 106:31-35
10. Warejcka DJ, Harvey R, Taylor BJ et al (1996) A population of cells isolated from rat heart capable of differentiating into several mesodermal phenotypes. J Surg Res 62:233-242
11. Hierlihy AM, Seale P, Lobe CG et al (2002) The post-natal heart contains a myocardial stem cell population. FEBS Lett 530:239-243
12. Beltrami AP, Barlucchi L, Torella D et al (2003) Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114:763-776
13. Laugwitz KL, Moretti A, Lam J et al (2005) Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433:647-653
14. Oyama T, Nagai T, Wada H et al (2007) Cardiac side population cells have a potential to migrate and differentiate into cardiomyocytes in vitro and in vivo. J Cell Biol 176:329-341
15. Bearzi C, Rota M, Hosoda T et al (2007) Human cardiac stem cells. Proc Natl Acad Sci USA 104:14068-14073
16. Tang YL, Shen L, Qian K, Phillips MI (2007) A novel two-step procedure to expand cardiac Sca-1+ cells clonally. Biochem Biophys Res Commun 359:877-883
17. Smith RR, Barile L, Cho HC et al (2007) Regenerative potential of cardiosphere derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 115:896-908
18. Andersen DC, Andersen P, Schneider M et al (2009) Murine cardiospheres are not a source of stem cells with cardiomyogenic potential. Stem Cells 27:1571-1581
19. Shiba Y, Fernandes S, Zhu WZ et al (2012) Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature 489:322-325
20. Kao RL, Rizzo C, Magovern GJ (1989) Satellite cells for myocardial regeneration. Physiologist 32:220
21. Kao RL, Chiu RCJ (1997) Satellite cell implantation. In: Kao RL, Chiu RCJ (eds) Cellular cardiomyoplasty: myocardial repair with cell implantation. Chapman & Hall, New York, pp 129-162
22. Menasché P, Hagège AA, Scorsin M et al (2001) Myoblast transplantation for heart failure. Lancet 357:279-280
23. Mauro A (1978) Muscle regeneration. Raven, New York
24. Pallafacchina G, Blaauw B, Schiaffi no S (2012) Role of satellite cells in muscle growth and maintenance of muscle mass Nutr Metab Cardiovasc Dis [Epub ahead of print]
25. Mauro A (1961) Satellite cells of skeletal muscle fi bers. J Biophys Biochem Cytol 9:493-495
26. Usas A, Ma?iulaitis J, Ma?iulaitis R et al (2011) Skeletal muscle-derived stem cells: implications for cell-mediated therapies. Medicina (Kaunas) 47:469-479
27. Aziz A, Sebastian S, Dilworth FJ (2012) The origin and fate of muscle satellite cells. Stem Cell Rev 8:609-622
28. Menasché P (2011) Stem cell therapy for chronic heart failure: lessons from a 15-year experience. C R Biol 334:489-496
29. Menasche P (2011) Cardiac cell therapy: lessons from clinical trials. J Mol Cell Cardiol 50:258-265
30. Friedenstein AJ (1976) Precursor cells of mechanocytes. Int Rev Cytol 47:327-359
31. Prockop DJ (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71-74
32. Chamberlain G, Fox J, Ashton B, Middleton J (2007) Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25:2739-2749
33. Dominici M, Le Blanc K, Mueller I et al (2006) Minimal criteria for defi ning multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317
34. Tomita S, Li RK, Weisel RD et al (1999) Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 100(19 Suppl):II247-II256
35. Wang JS, Shum-Tim D, Galipeau J et al (2000) Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. J Thorac Cardiovasc Surg 120:999-1005
36. Orlic D, Kajstura J, Chimenti S et al (2001) Bone marrow cells regenerate infarcted myocardium. Nature 410:701-705
37. Wu KH, Mo XM, Han ZC, Zhou B (2011) Stem cell engraftment and survival in the ischemic heart. Ann Thorac Surg 92:1917-1925
38. Hoover-Plow J, Gong Y (2012) Challenges for heart disease stem cell therapy. Vasc Health Risk Manag 8:99-113
39. Wen Y, Meng L, Xie J, Ouyang J (2011) Direct autologous bone marrow-derived stem cell transplantation for ischemic heart disease: a metaanalysis. Expert Opin Biol Ther 11:559-567
40. Wen Y, Meng L, Ding Y, Ouyang J (2011) Autologous transplantation of blood-derived stem/progenitor cells for ischaemic heart disease. Int J Clin Pract 65:858-865
41. Zuk PA, Zhu M, Mizuno H et al (2001) Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7:211-228
42. Halvorsen YD, Franklin D, Bond AL et al (2001) Extracellular matrix mineralization and osteoblast gene expression by human adipose tissue-derived stromal cells. Tissue Eng 7:729-741
43. Zhu Y, Liu T, Song K et al (2008) Adiposederived stem cell: a better stem cell than BMSC. Cell Biochem Funct 26:664-675
44. van Dijk A, Naaijkens BA, Jurgens WJ et al (2011) Reduction of infarct size by intravenous injection of uncultured adipose derived stromal cells in a rat model is dependent on the time point of application. Stem Cell Res 7:219-229
45. Sun CK, Yen CH, Lin YC et al (2011) Autologous transplantation of adipose-derived mesenchymal stem cells markedly reduced acute ischemia-reperfusion lung injury in a rodent model. J Transl Med 9(118):1-13
46. Cawthorn WP, Scheller EL, MacDougald OA (2012) Adipose tissue stem cells: the great WAT hope. Trends Endocrinol Metab 23:270-277
47. Planat-Bénard V, Menard C, André M et al (2004) Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ Res 94:223-229
48. Rangappa S, Fen C, Lee EH et al (2003) Transformation of adult mesenchymal stem cells isolated from the fatty tissue into cardiomyocytes. Ann Thorac Surg 75:775-779
49. Chang W, Lim S, Song BW et al (2012) Phorbol myristate acetate differentiates human adipose-derived mesenchymal stem cells into functional cardiogenic cells. Biochem Biophys Res Commun 424:740-746
50. Madonna R, Geng YJ, De Caterina R (2009) Adipose tissue-derived stem cells: characterization and potential for cardiovascular repair. Arterioscler Thromb Vasc Biol 29:1723-1729
51. Bai X, Alt E (2010) Myocardial regeneration potential of adipose tissue-derived stem cells. Biochem Biophys Res Commun 401:321-326
52. Oh H, Bradfute SB, Gallardo TD et al (2003) Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci USA 100:12313-12318
53. Messina E, De Angelis L, Frati G et al (2004) Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 95:911-921
54. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fi broblast cultures by defi ned factors. Cell 126:663-676
55. Takahashi K, Tanabe K, Ohnuki M et al (2007) Induction of pluripotent stem cells from adult human fi broblasts by defi ned factors. Cell 131:861-872
56. Robinton DA, Daley GQ (2012) The promise of induced pluripotent stem cells in research and therapy. Nature 481:295-305
57. Oh SI, Lee CK, Cho KJ et al (2012) Technological progress in generation of induced pluripotent stem cells for clinical applications Scientifi cWorldJournal 2012: 417809. Epub 2012 Mar 12
58. Yamanaka S (2012) Induced pluripotent stem cells: past, present, and future. Cell Stem Cell 10:678-684
59. Greenow K, Clarke AR (2012) Controlling the stem cell compartment and regeneration in vivo: the role of pluripotency pathways. Physiol Rev 92:75-99
60. Oh Y, Wei H, Ma D et al (2012) Clinical applications of patient-specifi c induced pluripotent stem cells in cardiovascular medicine. Heart 98:443-449
61. Okita K, Nakagawa M, Hyenjong H et al (2008) Generation of mouse induced pluripotent stem cells without viral vectors. Science 322:949-953
62. Tang C, Lee AS, Volkmer JP et al (2011) An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells. Nat Biotechnol 29:829-834
63. Nelson TJ, Martinez-Fernandez A, Yamada S et al (2009) Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation 120:408-416
64. Mauritz C, Martens A, Rojas SV et al (2011) Induced pluripotent stem cell (iPSC)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction. Eur Heart J 32:2634-2641
65. Choudry FA, Mathur A (2011) Stem cell therapy in cardiology. Regen Med 6(6 Suppl):17-23
66. Malliaras K, Marbán E (2011) Cardiac cell therapy: where we've been, where we are, and where we should be headed. Br Med Bull 98:161-185
67. Abdelli LS, Merino H, Rocher CM, Singla DK (2012) Cell therapy in the heart. Can J Physiol Pharmacol 90:307-315
68. Duran JM, Taghavi S, George JC (2012) The need for standardized protocols for future clinical trials of cell therapy. Transl Res 160(6):399-410
69. Durdu S, Deniz GC, Dogan A et al (2012) Stem cell mediated cardiovascular repair. Can J Physiol Pharmacol 90:337-351
70. Al Kindi A, Ge Y, Shum-Tim D, Chiu RC (2008) Cellular cardiomyoplasty: routes of cell delivery and retention. Front Biosci 13:2421-2434
71. Anderl JN, Robey TE, Stayton PS, Murry CE (2009) Retention and biodistribution of microspheres injected into ischemic myocardium. J Biomed Mater Res A 88:704-710
72. Menasché P, Alfi eri O, Janssens S et al (2008) The myoblast autologous grafting in ischemic cardiomyopathy (MAGIC) trial: fi rst randomized placebo-controlled study of myoblast transplantation. Circulation 117:1189-1200
73. Povsic TJ, O'Connor CM, Henry T et al (2011) A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarction. Am Heart J 162:654-662
74. Duckers HJ, Houtgraaf J, Hehrlein C et al (2011) Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trial. EuroIntervention 6:805-812
75. Beitnes JO, Hopp E, Lunde K et al (2009) Long-term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomised, controlled study. Heart 95:1983-1989
76. Assmus B, Rolf A, Erbs S et al (2010) Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction. Circ Heart Fail 3:89-96
77. Pokushalov E, Romanov A, Chernyavsky A et al (2010) Effi ciency of intramyocardial injections of autologous bone marrow mononuclear cells in patients with ischemic heart failure: a randomized study. J Cardiovasc Transl Res 3:160-168
78. Ahmadi H, Farahani MM, Kouhkan A et al (2012) Five-year follow-up of the local autologous transplantation of CD133+ enriched bone marrow cells in patients with myocardial infarction. Arch Iran Med 15:32-35
79. van der Laan A, Hirsch A, Nijveldt R et al (2008) Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, fi rst results. Neth Heart J 16:436-439
80. Yousef M, Schannwell CM, Köstering M et al (2009) The BALANCE Study: clinical benefi t and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction. J Am Coll Cardiol 53:2262-2269
81. Strauer BE, Yousef M, Schannwell CM (2010) The acute and long-term effects of intracoronary Stem cell Transplantation in 191 patients with chronic heARt failure: the STAR-heart study. Eur J Heart Fail 12:721-729
82. Lamy A, Devereaux PJ, Prabhakaran D et al (2012) Off-pump or on-pump coronaryartery bypass grafting at 30 days. N Engl J Med 366:1489-1497
83. Clifford DM, Fisher SA, Brunskill SJ et al (2012) Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev 2, CD006536
84. Zhao Q, Ye X (2011) Additive value of adult bone-marrow-derived cell transplantation to conventional revascularization in chronic ischemic heart disease: a systemic review and metaanalysis. Expert Opin Biol Ther 11:1569-1579
85. Donndorf P, Kundt G, Kaminski A et al (2011) Intramyocardial bone marrow stem cell transplantation during coronary artery bypass surgery: a meta-analysis. J Thorac Cardiovasc Surg 142:911-920
86. Qayyum AA, Haack-Sørensen M, Mathiasen AB et al (2012) Adipose-derived mesenchymal stromal cells for chronic myocardial ischemia (MyStromalCell Trial): study design. Regen Med 7:421-428
87. Houtgraaf JH, den Dekker WK, van Dalen BM et al (2012) First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 59:539-540
88. Li TS, Cheng K, Malliaras K et al (2012) Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair effi cacy with cardiosphere-derived cells. J Am Coll Cardiol 59:942-953
89. Makkar RR, Smith RR, Cheng K et al (2012) Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 379:895-904
90. Bolli R, Chugh AR, D'Amario D et al (2012) Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 378:1847-1857
91. Tatooles A, Stoddard MF, Lima JA et al (2012) Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance. Circulation 126(11 Suppl 1):S54-S64
92. Kao RL, Ganote E, Pennington DG, Borwder IW (2007) Myocardial regeneration, tissue engineering and therapy. In: Prakash S (ed) Artifi cial cells, cell engineering and therapy, 1st edn. Woodhead Publishing Ltd., Cambridge, England, pp 349-365
93. Ellison GM, Torella D, Dellegrottaglie S et al (2011) Endogenous cardiac stem cell activation by insulin-like growth factor-1/hepatocyte growth factor intracoronary injection fosters survival and regeneration of the infarcted pig heart. J Am Coll Cardiol 58:977-986
94. Cheng K, Li TS, Malliaras K et al (2010) Magnetic targeting enhances engraftment and functional benefi t of iron-labeled cardiospherederived cells in myocardial infarction. Circ Res 106:1570-1581
95. Lu HH, Li YF, Sheng ZQ, Wang Y (2012) Preconditioning of stem cells for the treatment of myocardial infarction. Chin Med J (Engl) 125:378-384
96. Haider HK, Ashraf M (2005) Bone marrow stem cell transplantation for cardiac repair. Am J Physiol Heart Circ Physiol 288: H2557-H2567
97. Bittira B, Kuang JQ, Al-Khaldi A, Shum-Tim D, Chiu RC (2002) In vitro preprogramming of marrow stromal cells for myocardial regeneration. Ann Thorac Surg 74:1154-1159
98. Grajales L, García J, Geenen DL (2012) Induction of cardiac myogenic lineage development differs between mesenchymal and satellite cells and is accelerated by bone morphogenetic protein-4. J Mol Cell Cardiol 53:382-391